New drug combo aims to shrink lung tumors in early trial
NCT ID NCT06448754
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study tests a new drug called volrustomig combined with other cancer treatments for people with advanced non-small cell lung cancer. The main goals are to check safety and see if tumors shrink. About 180 adults will take part in this early-stage trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
COMPLETEDLos Angeles, California, 90067, United States
-
Research Site
WITHDRAWNGrand Junction, Colorado, 81501, United States
-
Research Site
WITHDRAWNWheat Ridge, Colorado, 80033, United States
-
Research Site
WITHDRAWNBaltimore, Maryland, 21231, United States
-
Research Site
WITHDRAWNDetroit, Michigan, 48202, United States
-
Research Site
ACTIVE_NOT_RECRUITINGChapel Hill, North Carolina, 27514, United States
-
Research Site
WITHDRAWNTacoma, Washington, 98405, United States
-
Research Site
WITHDRAWNMontreal, Quebec, H4A 3J1, Canada
-
Research Site
RECRUITINGBeijing, 100730, China
-
Research Site
RECRUITINGHangzhou, 310014, China
-
Research Site
RECRUITINGJinan, 250013, China
-
Research Site
RECRUITINGYantai, 264000, China
-
Research Site
RECRUITINGZhengzhou, 450000, China
-
Research Site
RECRUITINGBois-Guillaume, 76031, France
-
Research Site
RECRUITINGCaen, 14076, France
-
Research Site
WITHDRAWNCréteil, 94000, France
-
Research Site
RECRUITINGDijon, 21079, France
-
Research Site
RECRUITINGMontpellier, 34070, France
-
Research Site
RECRUITINGBatumi, 6010, Georgia
-
Research Site
RECRUITINGTbilisi, '0159, Georgia
-
Research Site
RECRUITINGTbilisi, 0112, Georgia
-
Research Site
RECRUITINGTbilisi, 0114, Georgia
-
Research Site
RECRUITINGTbilisi, 0144, Georgia
-
Research Site
RECRUITINGTbilisi, 186, Georgia
-
Research Site
RECRUITINGAthens, 115 27, Greece
-
Research Site
RECRUITINGAthens, 12462, Greece
-
Research Site
RECRUITINGElaiones, 546 23, Greece
-
Research Site
RECRUITINGPiraeus, 185 47, Greece
-
Research Site
RECRUITINGThessaloniki, 57001, Greece
-
Research Site
RECRUITINGGenoa, 16132, Italy
-
Research Site
RECRUITINGMeldola, 47014, Italy
-
Research Site
RECRUITINGMilan, 20133, Italy
-
Research Site
RECRUITINGNaples, 80131, Italy
-
Research Site
RECRUITINGOrbassano, 10043, Italy
-
Research Site
RECRUITINGPerugia, 06132, Italy
-
Research Site
RECRUITINGRozzano, 20089, Italy
-
Research Site
RECRUITINGUdine, 33100, Italy
-
Research Site
RECRUITINGVerona, 37134, Italy
-
Research Site
RECRUITINGKuala Lumpur, 59100, Malaysia
-
Research Site
RECRUITINGKuching, 93586, Malaysia
-
Research Site
RECRUITINGPerai, 13700, Malaysia
-
Research Site
RECRUITINGLisbon, 1169-050, Portugal
-
Research Site
RECRUITINGLisbon, 1400-038, Portugal
-
Research Site
WITHDRAWNLisbon, 1500-458, Portugal
-
Research Site
RECRUITINGLisbon, 1649-035, Portugal
-
Research Site
RECRUITINGPorto, 4099-001, Portugal
-
Research Site
WITHDRAWNPorto, 4100-180, Portugal
-
Research Site
RECRUITINGCluj-Napoca, 400641, Romania
-
Research Site
RECRUITINGCraiova, 200542, Romania
-
Research Site
RECRUITINGFloreşti, 407280, Romania
-
Research Site
WITHDRAWNBelgrade, 11000, Serbia
-
Research Site
RECRUITINGBelgrade, 11000, Serbia
-
Research Site
WITHDRAWNKamenitz, 21204, Serbia
-
Research Site
WITHDRAWNKragujevac, 34000, Serbia
-
Research Site
COMPLETEDSeongnam, 13620, South Korea
-
Research Site
RECRUITINGSeoul, 03722, South Korea
-
Research Site
WITHDRAWNSeoul, 06591, South Korea
-
Research Site
RECRUITINGSuwon, 16247, South Korea
-
Research Site
RECRUITINGA Coruña, 15009, Spain
-
Research Site
RECRUITINGAlcorcón, 28922, Spain
-
Research Site
RECRUITINGBarcelona, 08041, Spain
-
Research Site
RECRUITINGMadrid, 28041, Spain
-
Research Site
RECRUITINGMálaga, 29004, Spain
-
Research Site
RECRUITINGPamplona, 31008, Spain
-
Research Site
RECRUITINGSantander, 39008, Spain
-
Research Site
RECRUITINGSantiago de Compostela, 15706, Spain
-
Research Site
RECRUITINGValencia, 46015, Spain
-
Research Site
RECRUITINGValencia, 46026, Spain
-
Research Site
WITHDRAWNBasel, 4031, Switzerland
-
Research Site
RECRUITINGGeneva, 1205, Switzerland
-
Research Site
RECRUITINGLausanne, 1011, Switzerland
-
Research Site
RECRUITINGWinterthur, 8401, Switzerland
-
Research Site
RECRUITINGZurich, 8091, Switzerland
-
Research Site
RECRUITINGChanghua, 50006, Taiwan
-
Research Site
RECRUITINGNew Taipei City, 23561, Taiwan
-
Research Site
RECRUITINGTaipei, 106, Taiwan
-
Research Site
RECRUITINGTaipei, 110, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can a radioactive tracer reveal whether immunotherapy is working?
- Can a new nucleotide analogue boost cancer treatment?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can standard cancer treatment wake up the immune system? a study investigates.